MicuRx Pharmaceuticals successfully completed more than 700 million yuan of E-round financing, setting a new record for financing of new antibacterial drug R&D enterprises in recent years

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...